Matulewicz Lab Team
Our lab comprises scientists with expertise in urologic oncology disease management, health services and disparities research, implementation science, and behavioral smoking cessation.
Dr. Matulewicz is an assistant professor in the Departments of Urology and Population Health at NYU Langone and a fellowship-trained urologic oncologist. Dr. Matulewicz graduated from Tufts University School of Medicine in Boston and completed residency at Northwestern Memorial Hospital in Chicago. This was followed by a Society of Urologic Oncology clinical fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in New York City. He is trained in all aspects of urologic oncology disease management including endoscopic, open, laparoscopic, and robotic approaches.
Dr. Matulewicz has led several grant-funded research projects, is the author of over 50 publications and 2 book chapters, and has been a featured speaker at several national and international medical conferences. His main research interests are improving disparities in the surgical care of urologic cancers and redesigning the diagnostic evaluation approach to hematuria. He currently has an oncology-focused clinical practice at NYC Health + Hospitals/Bellevue and the Manhattan campus of the VA NY Harbor Health system.
Dr. Matulewicz is an NYU Doctor Radio host of the Men’s Health show on Wednesday nights from 6:00PM to 8:00PM. He is a native New Yorker and enjoys Long Island’s beaches and traveling to ski and hike when not in the lab or clinical practice.
Dr. Makarov is Dr. Matulewicz’s primary research mentor, and the two have had a mentorship relationship since 2017, resulting in weekly mentorship and research meetings, joint research projects, and co-authored publications. A leading urologist and health services researcher based at the Manhattan campus of the VA NY Harbor Health system, Dr. Makarov is an associate professor in the Departments of Urology and Population Health at NYU Langone, and has deep expertise in implementation science and urologic oncology. He received a U.S. Department of Veterans Affairs (VA) Career Development Award and currently leads the VA-Prostate Cancer Foundation Center of Excellence at the Manhattan campus.
Dr. Makarov is also the primary investigator of a randomized trial funded by the VA’s Health Services Research and Development Service to implement and study an intervention to promote guideline-concordant prostate cancer imaging at 10 sites across the Veteran Health Administration. Finally, he is the principle investigator of a study funded by the National Institute on Minority Health and Health Disparities, part of the National Institutes of Health, to optimize the use of community health workers to promote shared decision making among Black men considering prostate cancer screening.
Dr. Sherman is Dr. Matulewicz’s primary tobacco-related and smoking cessation research mentor; the senior health services researcher at the Manhattan campus of the VA NY Harbor Health system; and a professor in the Departments of Population Health, Medicine, and Psychiatry at NYU Langone. He is a recognized leader in the development and implementation of behavioral smoking cessation interventions for physicians and patients.
Dr. Sherman’s work, focusing on smoking cessation in primary care, has received seven National Institutes of Health or U.S. Department of Veterans Affairs grants in the past five years. Last, but not least, he has also mentored six career development awardees, all of whom have subsequently received independent funding.